Mucinex
Chest Congestion, Mucinex 12 Hour Extended Release Tablets, 68Ct, 600 Mg Guaifenesin Relieves Chest Congestion Caused By Excess Mucus, #1 Doctor Recommended Otc Expectorant
OKAY
Product Code:
B01FGHSJY0
UPC:
8329213764225
Package Quantity:
2.9 Ounces
Country Of Origin:
USA
₹6,535.00
Chest Congestion, Mucinex 12 Hour Extended Release Tablets, 68Ct, 600 Mg Guaifenesin Relieves Chest Congestion Caused By Excess Mucus, #1 Doctor Recommended Otc Expectorant
₹6,535.00
Mucinex 12 Hour Extended-Release Bi-Layer Tablets: Clinically Proven To Last Up To 12 Hours; It Provides Powerful Relief For Your Chest Congestion Symptoms Treated: Relieves Chest Congestion Caused By Excess Mucus By Making Your Cough More Productive One Easy Pill: A Unique Bi-Layer Tablet, One Layer For Immediate Release, The Other Layer For Extended Release So The Medicine Starts To Release Right Away And Lasts For Up To 12 Hours Ingredients: Guaifenesin (600 Mg) Is An Expectorant That Helps Reduce Chest Congestion Caused By Colds, Infections Or Irritants Continuous Relief: Mucinex Lasts Up To 12 Hours So You Can Say Goodbye To Retaking Medicine Every 4 Hours Mucinex Extended-Release Bi-Layer Tablets Provide Powerful Symptom Relief. The Product Relieves Chest Congestion, Thins And Loosens Mucus And Lasts For 12 Hours. It Contains A Unique Bi-Layer Tablet - One Layer For Immediate Release And One Layer For Extended Release, So The Medicine Starts To Release Right Away And Lasts For Up To 12 Hours, So You Can Say Goodbye To Retaking Medicine Every 4 Hours. Mucinex Is The #1 Cold And Cough Brand Doctors Trust* And The #1 Pharmacist Recommended Brandâ As Well. This Product Contains 120 Tablets. It Can Be Used By Adults And Children 12 Years Of Age And Over. Key Symptoms Relieved: Mucinex Extended-Release Bi-Layer Tablets Relieve Chest Congestion And Thin And Loosen Mucus Active Ingredient: Contains Guaifenesin Which Is An Expectorant That Relieves Chest Congestion And Thins & Loosens Mucus Making Cough More Productive Use As Directed *Iqvia Using Provoice Survey, December 2022 ÂU.S. News & World Report/Pharmacy Times 2023-2024